BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 18629779)

  • 21. Markers of progression and invasion in short term follow up of untreated breast cancer patients.
    Rabi ZA; Todorović-Raković N; Vujasinović T; Milovanović J; Nikolić-Vukosavljević D
    Cancer Biomark; 2015; 15(6):745-54. PubMed ID: 26406416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Message RNA expression of LUNX, CK19 and CEA genes in NSCLC with micrometastasis in lymph nodes].
    Wang WB; Cui YG; Yao SY
    Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):121-4. PubMed ID: 18646695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The balance of VEGF-C and VEGFR-3 mRNA is a predictor of lymph node metastasis in non-small cell lung cancer.
    Takizawa H; Kondo K; Fujino H; Kenzaki K; Miyoshi T; Sakiyama S; Tangoku A
    Br J Cancer; 2006 Jul; 95(1):75-9. PubMed ID: 16755294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular diagnosis of lymph node metastasis in patients with upper urinary tract cancer who underwent lymphadenectomy.
    Kodama Y; Kondo T; Matsumura N; Shimokawa T; Kohjimoto Y; Tanabe K; Hara I
    Int J Urol; 2017 Nov; 24(11):799-806. PubMed ID: 29027273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical significance of RT-PCR in detection of axillary lymph node micrometastases from breast cancer].
    Hao XB; Fu J; Qiu FH
    Ai Zheng; 2003 Sep; 22(9):964-7. PubMed ID: 12969530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of high-risk HPV DNA and CK19 in pelvic lymph nodes in stage Ia-IIa cervical cancer and their clinical value.
    Zhang F; Liu D; Lin B; Hao Y; Zhou D; Qi Y; Zhang S
    Oncol Rep; 2012 Jun; 27(6):1801-6. PubMed ID: 22407186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic diagnosis of micrometastasis based on SCC antigen mRNA in cervical lymph nodes of head and neck cancer.
    Hamakawa H; Fukizumi M; Bao Y; Sumida T; Onishi A; Tanioka H; Sato H; Yumoto E
    Clin Exp Metastasis; 1999; 17(7):593-9. PubMed ID: 10845558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Gene diagnosis and prognosis of mediastinal lymph node occult micrometastasis in non-small cell lung carcinoma].
    Wang Z; Yin H; Zhang L; Lan X; Li H
    Zhonghua Zhong Liu Za Zhi; 2002 May; 24(3):247-9. PubMed ID: 12515617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis.
    O-charoenrat P; Rhys-Evans P; Eccles SA
    Cancer; 2001 Aug; 92(3):556-68. PubMed ID: 11505400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantification of vascular endothelial growth factor-C and its receptor-3 messenger RNA with real-time quantitative polymerase chain reaction as a predictor of lymph node metastasis in human colorectal cancer.
    Kawakami M; Furuhata T; Kimura Y; Yamaguchi K; Hata F; Sasaki K; Hirata K
    Surgery; 2003 Mar; 133(3):300-8. PubMed ID: 12660643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients.
    Bostick PJ; Chatterjee S; Chi DD; Huynh KT; Giuliano AE; Cote R; Hoon DS
    J Clin Oncol; 1998 Aug; 16(8):2632-40. PubMed ID: 9704713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancer.
    Hashimoto I; Kodama J; Seki N; Hongo A; Yoshinouchi M; Okuda H; Kudo T
    Br J Cancer; 2001 Jul; 85(1):93-7. PubMed ID: 11437408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
    Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V
    Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of urokinase-type plasminogen activator (uPA) in invasive cervical cancer of the uterus.
    Sugimura M; Kobayashi H; Kanayama N; Terao T
    Gynecol Oncol; 1992 Sep; 46(3):330-6. PubMed ID: 1526511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular endothelial growth factor C expression is closely correlated with lymph node recurrence and poor prognosis in patients with early stage cervical cancer.
    DeMei M; XiangXin L; YongPing X; YongXia Y; YunHai Y; Lin Z
    J Int Med Res; 2013 Oct; 41(5):1541-9. PubMed ID: 23963849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Urokinase-type plasminogen activator as a predictor for lymph nodes metastasis of uterine cervical cancer].
    Fujishiro S; Kobayashi H; Terao T
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Feb; 46(2):129-36. PubMed ID: 8126385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid detection of metastasis of gastric cancer using reverse transcription loop-mediated isothermal amplification.
    Horibe D; Ochiai T; Shimada H; Tomonaga T; Nomura F; Gun M; Tanizawa T; Hayashi H
    Int J Cancer; 2007 Mar; 120(5):1063-9. PubMed ID: 17139607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic relevance of TGF-beta1 and PAI-1 in cervical cancer.
    Hazelbag S; Kenter GG; Gorter A; Fleuren GJ
    Int J Cancer; 2004 Dec; 112(6):1020-8. PubMed ID: 15386352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of VEGF-C and VEGF-D as significant markers for assessment of lymphangiogenesis and lymph node metastasis in non-small cell lung cancer.
    Feng Y; Wang W; Hu J; Ma J; Zhang Y; Zhang J
    Anat Rec (Hoboken); 2010 May; 293(5):802-12. PubMed ID: 20225197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The utility of rapid diagnosis of lymph node metastasis in gastric cancer using a multiplex real-time reverse transcription polymerase chain reaction assay.
    Yanagita S; Natsugoe S; Uenosono Y; Arigami T; Funasako Y; Hirata M; Kozono T; Ehi K; Arima H; Green G; Wang Y; Aikou T
    Oncology; 2009; 77(3-4):205-11. PubMed ID: 19729978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.